This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Dewey A. Nelson, MD
48 Omega Dr Newark, DE 19713

Arch Neurol. 1990;47(3):255.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—In response to my July 1988 review article in the ARCHIVES¹ concerning intraspinal steroid therapy, a recent letter by Haynes et al² was published, which further extends the controversy that began in 1970.³ Haynes et al² stated that epidural instillation of certain steroid compounds was a safe and effective treatment for chronic low back pain syndromes in which the pathologic findings were due to inflammation of nerve roots; however, intrathecal therapy was described as risky. In my experience, the concept of treating "inflammation" is doubtful at best, due to the fact that most patients present with chronic pain due to chronic cicatrix. The core of the present conflict, however, revolves around the toxicity of polyethylene glycol contained in several steroid compounds now in use, particularly methylprednisolone acetate and triamcinolone diacetate. Beginning in 1980, after The Upjohn Company (Kalamazoo, Mich) issued a warning concerning . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?